Human susceptibility and resistance to Norwalk virus infection

Article Abstract:

The protective immunity to Norwalk virus infection in humans is multifactorial. Research reveals that 29% of the study population is homozygous recessive for the secretor phenotype gene FUT2 and does not express the H type-1 oligosaccharide ligand involved in the virus binding. Furthermore, a portion of the susceptible population exhibit FUT gene and hence show resistance to infection, indicating to the existence of a memory immune response.

Analysis, Infection, Population genetics, Disease susceptibility, Norwalk virus

---

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

Article Abstract:

Research describes modification of the live tuberculosis BCG vaccine by the introduction of region of deletion-1 locus into the Mycobacterium tuberculosis. Results indicate that introduction of the complete locus, containing a minimum of 11 genes, leads to the full secretion of the antigens and immune response.

United Kingdom, Innovations, Evaluation, Physiological aspects, Design and construction, Immune response, Recombinant molecules, BCG vaccines, BCG, Tuberculosis vaccines

---

A low-carb diet for a high-octane pathogen

Article Abstract:

A brief description on the role of one metabolic pathway required for Mycobacterium tuberculosis to survive on host-derived lipids is presented. It might guide future efforts to develop new intervention strategies based on an understanding of the in vivo physiology of the bacterium.

Lipids, Pathogenic microorganisms

Similar abstracts:

• Abstracts: Public health: surveillance, prevention, and control of nosocomial infections. Transmission of nosocomial Legionnaires disease
• Abstracts: Nutrition and pregnancy. Group B streptococci and early onset neonatal infection. Nutrition in pregnancy
• Abstracts: NT campaign will support nurses in the fight against MRSA infection. SARS: current knowledge and management
• Abstracts: Human tissue-engineered blood vessels for adult arterial revascularization. Engineered antibodies
• Abstracts: Mibefradil - a new calcium channel blocker. Nesiritide for decompensated congestive heart failure. Eplerenone (Inspra)

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.